Dr. Chigurupati Centre of Excellence will advance eco-friendly drug development, green technology IP, and training of future scientists, combining Granules India’s industry expertise with NIPER Mohali’s academic leadership.
India’s effort to build a sustainable pharmaceutical ecosystem has received a significant boost with the establishment of the Dr. Chigurupati Centre of Excellence at NIPER Mohali, created in partnership with Granules India.
The facility is dedicated to advancing green pharmaceutical research, with a focus on developing eco-friendly drug manufacturing methods, building intellectual property around green technologies, and equipping future scientists with skills in sustainable drug design.
The centre is named after Dr. Krishna Prasad Chigurupati, Chairman and Managing Director of Granules India, in recognition of his contributions to the pharmaceutical sector and his advocacy for sustainable practices. The academic direction will be led by Dr. Arvind K. Bansal, with overall guidance from Prof. Dulal Panda, Director of NIPER Mohali.
Executives from Granules India said the initiative reflects the company’s vision of aligning business growth with environmental responsibility. They added that the collaboration with NIPER brings together the strengths of industry and academia to address global calls for greener healthcare supply chains.
For NIPER Mohali, the centre is an opportunity to strengthen its research ecosystem and provide students with direct exposure to challenges at the intersection of science, business, and sustainability. Faculty members highlighted that such collaborations can help Indian scientists lead the way in eco-friendly pharmaceuticals, at a time when global regulators are pushing for lower carbon footprints across drug lifecycles.
Observers in the pharmaceutical sector noted that partnerships like this are vital as India aims to maintain its position as the “pharmacy of the world” while also meeting sustainability benchmarks set by global markets. By fostering innovation in green chemistry and drug design, the centre is expected to play a role in shaping the next generation of pharmaceutical practices.
At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.
This was beautiful Admin. Thank you for your reflections.
[…] gives directors awareness of duties. But when facing complex disputes, regulatory filings, or whistle-blower cases, directors […]
https://shorturl.fm/Me8ey